Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - ENDRA Life Sciences Inc. | ndra_ex991.htm |
8-K - CURRENT REPORT - ENDRA Life Sciences Inc. | ndra_8k.htm |
Exhibit 10.1
|
AMENDMENT 2
|
TO THE
|
COLLABORATIVE RESEARCH AGREEMENT
|
BETWEEN
|
GENERAL ELECTRIC COMPANY
|
AND
|
ENDRA LIFE SCIENCES INC.
|
|
This
Amendment 2 to the Collaborative Research Agreement ("Amendment"),
effective as of the last date of signing below ("Effective Date"),
amends the TERM between General Electric ("GE") & ENDRA Life
Sciences Inc. ("Endra"), which became effective as of April 22,
2016, as amended by that certain Amendment 1 to the Collaborative
Research Agreement, dated April 21, 2017
("Agreement").
|
RECITALS
|
WHEREAS,
the parties wish to amend the Agreement to provide for a revised
TERM, which includes changes to the Agreement as set forth
below;
|
THEREFORE,
the parties hereby agree to the following amendment:
|
1. Section 9.1
of Collaborative Research Agreement shall be deleted and restated
as follows:
This Agreement will remain in effect until January 22, 2020 unless
terminated sooner or extended in writing signed by the parties in
accordance with this Agreement.
|
2. Capitalized
terms not defined in this Amendment will have the meanings assigned
in the Agreement.
|
3. Except as
explicitly modified, all terms, conditions and provisions of the
Agreement shall continue in full force and effect.
|
4. In the
event of any inconsistency or conflict between the Agreement and
this Amendment, the terms, conditions and provisions of this
Amendment shall govern and control.
|
5. This
Amendment and the Agreement constitute the entire and exclusive
agreement between the parties with respect to this subject matter.
All previous discussions and agreements with respect to this
subject matter are superseded by the Agreement and this
Amendment.
|
Acceptance
of these terms is documented by the signature and date of the
responsible parties in the space designated below.
GE Healthcare
|
ENDRA Life Sciences Inc.
|
Signature: /s/
Brian
McEathron
|
Signature:
/s/ Francois
Michelon
|
Name:
Brian McEathron
|
Name:
Francois
Michelon
|
Title:
GM General Imaging
Ultrasound
|
Title:
CEO
|
Date:
January 30,
2018
|
Date:
January 6,
2018
|